biotech stocks news from FierceBiotech
News
E&Y forecasts new wave of biotech deal-making
Ernst & Young took a look into biotechnology's crystal ball and came up with a Read more...
European investors sour on biotech market
There's a loud drumbeat of warnings coming from Europe over the sour state of biotech investing. Zhining Xu, an analyst at Seymour Pierce, tells the Financial Times that 2007 was a "Read more...
Biotech M&A has yet to reach its peak
In analyzing the PowerShares Dynamic Biotech & Genome ETF, a fund made up of primarily small- and medium-cap biotech stocks, Seeking Alpha notes that Big Pharma's appetite for biotech Read more...
CellCyte in 'precarious' shape after shares collapse
After a brief period as a high-flying stem cell company, CellCyte Genetics' share price Read more...
Big Biotech emerges as a shelter in economic storm
Veteran investors have long taken different views of biotechnology, sometimes in the course of a single day. And share prices regularly go on a Read more...
Amgen - Big Biotech's Stock Report
Company: Amgen Starting stock price: $70.37 Ending stock price: $46.44 Percent Change: 34% Scoop: The world's biggest biotech suffered its toughest year to date in 2007. Read more...
Genentech - Big Biotech's Stock Report
Company: Genentech Starting stock price: $81.80 Ending stock price: $67.07 Percent Change: -18% Scoop: Genentech's stock slowly declined in ’07 as investors realized that the company's amazing Read more...
Genzyme - Big Biotech's Stock Report
Company: Genzyme Starting stock price: $65.73 Ending stock price: $74.97 Percent Change: 12.97% Scoop: When Biogen Idec put itself up for sale, many wondered whether Genzyme would do the same, Read more...
Biogen Idec - Big Biotech's Stock Report
Company: Biogen Idec Starting stock price: $49.75 Ending stock price: $57.48 Percent Change: 16.26% Scoop: Biogen Idec had quite the year. Let's look at the clinical side of things first. A Phase II Read more...
Gilead Sciences - Big Biotech's Stock Report
Company: Gilead Sciences Starting stock price: $32.16 Ending stock price: $46.01 Percent Change: 43.06% Scoop: Gilead's big achievement of '07 was the Read more...
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets